Skip to main content

Asymmetric Dimethylarginine

Meaning

Asymmetric Dimethylarginine (ADMA) is an endogenous amino acid derivative that has emerged as a significant, independent cardiovascular risk factor and a key biomarker of endothelial dysfunction. Elevated plasma concentrations of ADMA are associated with impaired vascular health, reflecting a fundamental disruption in the body’s nitric oxide (NO) production pathway. This molecule is now recognized in clinical practice as a measurable indicator of compromised endothelial function, which is the earliest stage of atherosclerosis. Monitoring ADMA levels provides valuable insight into a patient’s vascular and cardiometabolic risk profile.